🔗 Permalink

Inventor profile of:

Rudolph E. Tanzi

City:

Hull, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2020-02-20

Top Assignees for applications by Rudolph E. Tanzi

The entities that hold a legal rights for patent applications filed by inventor Tanzi Rudolph E.:

The General Hospital Corporation 10 Boston, MA United States
The General Hospital Corporation d/b/a Massachusetts General Hospital 4 Boston, MA United States
The Regents of the University of California 2 Oakland, CA United States
D/B/A MASSACHUSETTS GENERAL HISPITAL 1 BOSTON, MA United States

Recent patent applications by Tanzi Rudolph E.

Rudolph E. Tanzi from Hull, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-02-20

US20200055840A1

Chemistry; metallurgy

Potent gamma-secretase modulators

#2 | 2018-04-05

US20180093967A1

Chemistry; metallurgy

Potent gamma-secretase modulators

#3 | 2015-08-06

US20150218259A9

Chemistry; metallurgy

ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS

#4 | 2014-12-25

US20140377267A1

Chemistry; metallurgy

ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS

#5 | 2013-01-24

US20130022994A1

Chemistry; metallurgy

REGULATION OF BACE DEGRADATION

#6 | 2012-05-10

US20120114635A1

Chemistry; metallurgy

ANTIBODIES TO CROSS-LINKED AMYLOID BETA OLIGOMERS

#7 | 2012-03-08

US20120058935A1

Human necessities

ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREFORE

#8 | 2011-07-21

US20110177543A1

Chemistry; metallurgy

Regulation of BACE degradation

#9 | 2010-12-09

US20100311726A1

Human necessities

REDUCTION OF BETA-AMYLOID LEVELS BY TREATMENT WITH THE SMALL MOLECULE DIFFERENTIATION-INDUCING FACTOR

#10 | 2010-05-06

US20100113570A1

Human necessities

PREVENTION AND TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION

#11 | 2008-05-22

US20080118499A1

Chemistry; metallurgy

Measurement of GGA proteins for diagnosing BACE associated disease

#12 | 2008-02-05

US10801087

Methods for identifying compounds that modulate stabilization of secretase-associated proteins

#13 | 2006-08-03

US20060172964A1

Chemistry; metallurgy

Methods for reducing amyloid beta levels

#14 | 2006-05-16

US9380704

Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator

#15 | 2006-04-06

US20060074104A1

Human necessities

Use of clioquinol for the therapy of alzheimer's disease

#16 | 2005-08-04

US20050170437A1

Physics

Methods and compositions relating to modulating amyloid precursor protein cleavage

#17 | 2005-06-02

US20050118226A1

Human necessities

Methods for treating ACAT-related diseases

#18 | 2005-05-26

US20050112543A1

Physics

Method of screening for drugs useful in treating Alzheimer's disease

#19 | 2005-05-03

US9065902

Purified 20 kDA presenilin 2 C-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2

#20 | 2005-01-13

US20050009031A1

Chemistry; metallurgy

Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases

InventorID:

53462 ⎘